1. Market Research
  2. > Cancer Industry

Leukemia Industry, September 2016 Market Reports from Top Publishers

You might be interested in: Molecular Diagnostic, Diagnostics, Cancer, Therapy, Blood Disease, Blood Supply, Pap Smear, Anti-Infective, Bone Marrow Transplant, Cancer Diagnostic, Clinical Trial, Cloud Computing, In Vitro Diagnostic Reagent, Stem Cell.


 
1-10 of about 300 reports for Leukemia

Purchase Reports From Reputable Market Research Publishers

T-Cell Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

T-Cell Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “T-Cell Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

Global Leukemia Partnering 2010 to 2016

Global Leukemia Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

Global Acute and Chronic Myelogenous Leukemia Partnering 2010 to 2016

Global Acute and Chronic Myelogenous Leukemia Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

Chronic Lymphocytic Leukemia (CLL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Chronic Lymphocytic Leukemia (CLL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Chronic Lymphocytic Leukemia (CLL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, ...

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights ...

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights ...

Meningeal Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Meningeal Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Meningeal Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights ...

B-Cell Chronic Lymphocytic Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

B-Cell Chronic Lymphocytic Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “B-Cell Chronic Lymphocytic Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, ...

Actinium Pharmaceuticals, Inc. - Product Pipeline Review - 2016

Actinium Pharmaceuticals, Inc. - Product Pipeline Review - 2016

  • $ 1 500
  • Company report
  • August 2016
  • by Global Markets Direct

Actinium Pharmaceuticals, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Actinium Pharmaceuticals, Inc. - Product Pipeline Review - 2016’, provides an overview of the Actinium ...

About 5 700 reports for Leukemia

Download Unlimited Documents from Trusted Public Sources

Blood Disease Statistics and Leukemia Statistics

  • January 2014
    265 pages
  • Blood Disease  

    Leukemia  

    Lymphoma  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.